SWI/SNF chromatin remodelling complex and retroviral gene silencing

Reviews in Medical Virology

Volumn 13, Issue 2, 2003, Pages 99-110

  Iba, Hideo ^a   Mizutani, Taketoshi ^a   Ito, Taiji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATIN; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; HOST RESISTANCE; NONHUMAN; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; TRANSGENE; VIRUS PATHOGENESIS; VIRUS REACTIVATION;

CELL CYCLE; CELL LINE; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE SILENCING; HUMANS; RETROVIRIDAE; TRANSCRIPTION FACTORS;

EID: 0037340978     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.378     Document Type: Review

References (86)

1. Stewart CL, Stuhlmann H, Jahner D, Jaenisch R. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc Natl Acad Sci USA 1982; 79: 4098-4102.
2. Cherry SR, Biniszkiewicz D, van Parijs L, Baltimore D, Jaenisch R. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 2000; 20: 7419-7426.
3. Jaenisch R, Schnieke A, Harbers K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc Natl Acad Sci USA 1985; 82: 1451-1455.
4. Bednarik DP, Cook JA, Pitha PM. Inactivation of the HIV LTR by DNA CpG methylation evidence for a role in latency. EMBO J 1990; 9: 1157-1164.
5. Hoeben RC, Migchielsen AA, van der Jagt RC, van Ormondt H, van der Eb AJ. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J Virol 1991; 65: 904-912.
6. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997; 13: 335-340.
7. Lorincz MC, Schuebeler D, Goeke SC, Walters M, Groudine M, Martin DIK. Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol Cell Biol 2000; 20: 842-850.
8. Chen WY, Bailey EC, McCune SL, Dong J-Y, Townes TM. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc Natl Acad Sci USA 1997; 94: 5798-5803.
9. Chen WY, Townes TM. Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc Natl Acad Sci USA 1997; 97: 377-382.
10. Muchardt C, Yaniv M. When the SWI/SNF complex remodels...the cell cycle. Oncogene 2001; 20: 3067-3075.
11. Ito T, Yamauchi M, Nishina M, et al. Identification of SWI/SNF complex subunit BAF60a as a determinant of transactivation potential of Fos/Jun diners. J Biol Chem 2001; 276: 2852-2857.
12. Mizutani T, Ito T, Nishina M, Yamamichi N, Watanabe A, Iba H. Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex. J Biol Chem 2002; 277: 15859-15864.
13. Simon JA, Tamkun JW. Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes. Curr Opin Genet Dev 2002; 12: 210-218.
14. Peterson CL, Workman JL. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr Opin Genet Dev 2000; 10: 187-192.
15. Klochendler-Yeivin A, Muchardt C, Yaniv M. SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Develop 2002; 12: 73-79.
16. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 1996; 10: 2117-2130.
17. Gebuhr TC, Bultman SJ, Magnuson T. Pc-G/trx-G and the SWI/SNF connection: developmental gene regulation through chromatin remodeling. Genesis 2000; 26: 189-197.
18. Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 1999; 22: 102-105.
19. Strobeck MW, Knudsen KE, Fribourg AF, et al. BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 2000; 97: 7748-7753.
20. Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 2002; 277: 22330-22337.
21. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 2000; 102: 257-265.
22. Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E. Cyclin E associates with BAF 155 and BRG, components of the mammalian SWI/SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol Cell Biol 1999; 19: 1460-1469.
23. Adler HT, Chinery R, Wu DY, Kussick SJ, Payne JM. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol 1999; 19: 7050-7060.
24. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001; 20: 2390-2400.
25. Jochum W, Passegu E, Wagner E. AP-1 in mouse development and tumorigenesis. Oncogene 2001; 20: 2401-2412.
26. Ui M, Mizutani T, Takada M, et al. Endogenous AP-1 levels necessary for oncogenic activity are higher than those sufficient to support normal growth. Biochem Biophys Res Commun 2000; 278: 97-105.
27. Curran T, Teich N. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein. J Virol 1982; 42: 114-122.
28. Maki Y, Bos TJ, Davis C, Starbuck M, Vogt PK. Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci USA 1987; 84: 2848-2852.
29. Suzuki T, Okuno H, Yoshida T, Endo T, Nishioka H, Iba H. Difference in transcriptional regulatory function between c-Fos and Fra2. Nucleic Acid Res 1991; 19: 5537-5542.
30. Burns JC, Friedmann T, Driever W, Burrascano M, Tee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037.
31. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994; 91: 9564-9568.
32. Arai T, Matsumoto K, Saitoh K, et al. A new system for stringent, high-titer VSV-G pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable 'pre-packaging' cell lines. J Virol 1998; 72: 1115-1121.
33. Iba H, Arai T, Ui M. Efficient production of VSV-G-pseudotyped retrovirus vectors using stable packaging cell lines. In Viral Vectors - Basic Science and Gene Therapy. Bio Techniques Books, Eaton Publishing: Natic, MA, 2000; 401-411.
34. Arai T, Takada M, Ui M, Iba H. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Virology 1999; 260: 109-115.
35. Ui M, Takada M, Arai T, et al. Retrovirus vectors designed for efficient transduction of cytotoxic or cytostatic genes. Gene Ther 1999; 6: 1670-1678.
36. + T-cell responses in the livers or peripheral blood of patients using autologous peripheral blood mononuclear cells as targets or stimulators. J Clin Microbiol 2001; 39: 3895-3901.
37. Koike C, Mizutani T, Ito T, et al. Introduction of wild type patched gene suppresses the oncogenic potential of human squamous cell. Oncogene 2002; 21: 2670-2678.
38. Loh TP, Sievert LL, Scott RW. Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells. Mol Cell Biol 1990; 10: 4045-4057.
39. Muchardt C, Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SW12 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 1993; 12: 4279-4290.
40. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SW12/SNF2 family necessary for normal mitotic growth and transcription. Nature 1993; 366: 170-174.
41. Dunaief JL, Strober BE, Guha S, et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 1994; 79: 119-130.
42. Swedlund B, Tavtigian SV, Teng DH, Lees E. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000; 60: 6171-6177.
43. DeCristofaro MF, Belz BL, Rorie CJ, Reisman DN, Wang W, Weisman BEJ. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Phys 2001; 186: 136-145.
44. LeGouy E, Tompson EM, Muchardt C, Renard J-P. Differential preimplantation regulation of two mouse homologues of the yeast SW12 protein. Develop Dynam 1998; 212: 38-48.
45. Komatsu Y, Tomizaki K-Y, Tsukamoto M, et al. CHAP31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Cancer Res 2001; 61: 4459-4466.
46. Flanagan JR, Becker KG, Ennist DL, et al. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol 1992; 12: 38-44.
47. Fritsch C, Brown JL, Kassis JA, Muller J. The DNA-binding polycomb group protein Pleiohomeotic mediates silencing of a Drosophila homeotic gene. Development 1999; 126: 3905-3913.
48. Sewalt RGAB, Lachner M, Vargas M, et al. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of polycomb group proteins. Mol Cell Biol 2002; 22: 5539-5553.
49. Hamer KM, Sewalt RG, Den Blaauwen JL, Hendrix T, Satijn DP, Otte AP. A panel of monoclonal antibodies against human Polycomb group proteins. Hybrid Hybridomics 2002; 21: 245-252.
50. Bestor TH. Gene silencing as a threat to the success of gene therapy. J Clin Invest 2000; 105: 409-411.
51. Kowenz-Leutz E, Leutz A. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell 1999; 4: 735-743.
52. Chiba H, Muramatsu M, Nomoto A, Kato H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res 22: 1815-1820.
53. Fryer CJ, Archer TK. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 1998; 393: 88-91.
54. Sudarsanam P, Lyer VR, Brown PO, Winston F. Wholegenome expression analysis of snf/swi mutants of Saccaromyces cerevisiae. Proc Natl Acad Sci USA 2000; 97: 3364-3369.
55. Liu R, Liu H, Chen X, Kirby M, Brown PO, Zhao K. Regulation of CFS1 promoter by the SWI/SNF-like BAF complex. Cell 2001; 106: 309-318.
56. Wu DY, Kalpana GV, Goff SP, Schubach WH. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF/SWI complex, hSNF5/Ini1. J Virol 1996; 70: 6020-6028.
57. Wu DY, Krumm A, Schubach WH. Promoter-specific targeting of human SWI/SNF complex by Epstein-Barr virus nuclear protein 2. J Virol 2000; 74: 8893-8903.
58. Lee D, Sohn H, Kalpana GV, Choe J. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 1999; 399: 487-491.
59. Landau NR. A cellular cofactor in HIV-1 assembly: INI1 is also an 'outtie'. Trends Pharmacol Sci 2002; 23: 252-253.
60. Kalpana GV, Marmon S, Wang W, Crabtree GR. Binding and stimulation of HIV-1 integrase by a human homology of yeast transcription factor SNF5. Science 1994; 266: 2002-2006.
61. Turelli P, Doucas V, Craig E, Manageat B, Klages N, Evance R. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: inteference with early steps of viral replication. Mol Cell 2001; 7: 1245-1254.
62. Yung E, Sorin M, Pal A, et al. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor. Nat Med 2001; 7: 920-926.
63. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293: 1074-1080.
64. Razin A. CpG methylation, chromatin structure and gene silencing - a three-way connection. EMBO J 1998; 17: 4905-4908.
65. Jackson JP, Lindroth AM, Gao X, Jacobsen SE. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 2002; 416: 556-560.
66. Vaucheret H, Fagard M. Transcriptional gene silencing in plants: targets, inducers and regulators. Trends Genet 2001; 17: 29-35.
67. Waterhouse PM, Wang M-B, Lough T. Gene silencing as an adaptive defence against viruses. Nature 2001; 411: 834-842.
68. Plasterk RHA. RNA silencing: the genome's immune system. Science 2002; 296: 1263-1265.
69. Scheid OM, Paszkowski J. Transcriptional gene silencing mutants. Plant Mol Biol 2000; 43: 235-241.
70. Jeddeloh JA, Stoker TL, Richards EJ. Maintenance of genomic methylation requires a SWI2/SNF2-like protein. Nature Genet 1999; 22: 94-97.
71. Amedeo P, Habu Y, Karin A, Scheid OM, Paszkowski J. Disruption of the plant gene MOM releases transcriptional silencing of methylated genes. Nature 2000; 405: 203-206.
72. Stokes TL, Richards EJ. Mum's the word: MOM and modifiers of transcriptional gene silencing. The Plant Cell 2000; 12: 1003-1006.
73. Hirochika H, Okamoto H, Kakutani T. Silencing of retrotransposons in Arabidopsis and reactivation by the ddm1 mutation. The Plant Cell 2000; 12: 357-368.
74. Bourc'his D, Bestor TH. Helicase homologues maintain cytosine methylation in plants and mammals. Bioessays 2002; 24: 297-299.
75. Gendrel AV, Lippman Z, Yordan C, Colot V, Martiessen R. Dependence of heterochromatic histone H3 methylation patterns on the Arabidopsis gene DDM1. Science 2002; 297: 1871-1873.
76. Vaucheret H, Beclin C, Fagard M. Post-transcriptional gene silencing in plants. J Cell Sci 2001; 114: 3083-3091.
77. Vance V, Vaucheret H. RNA silencing in plants defense and counterdefense. Science 2001; 292: 2277-2280.
78. Rovere CV, Vas MD, Hopp HE. RNA-mediated virus resistance. Curr Opin Biotechnol 2002; 13: 167-172.
79. Sijen T, Vijn I, Rebocho A, et al. Transcriptional and posttranscriptional gene silencing are mechanistically related. Curr Biol 2000; 11: 436-440.
80. Morel J-B, Mourrain P, Beclin C, Vaucheret H. DNA methylation and chromatin structure affect transcriptional and post-transcriptional transgene silencing in Arabidopsis. Curr Biol 2000; 10: 1591-1594.
81. Pal-Bhadra M, Bhadra U, Birchler JA. RNAi related mechanisms affect both transcriptional and posttranscriptional transgene silencing in Drosophila. Mol Cell 2002; 9: 315-327.
82. Hannon GJ. RNA interference. Nature 2002; 418: 244-251.
83. Wianny F, Zernivka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nature Cell Biol 1999; 2: 70-75.
84. Billy E, Brondani V, Zhang H, Muller U, Filipowicz W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci 2001; 98: 14428-14433.
85. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002; 418: 435-438.
86. Carmichael GG. Medicine: silencing viruses with RNA. Nature 2002; 418: 379-380.